By Angela Chen / Business Leader, Cell Therapy Asia
China is quickly becoming a world leader in biopharma, with rapid build-out of gene and cell therapy production capacity and a robust pipeline of drugs in development. GE supports growth of the industry with innovative manufacturing technologies and services.
China bets big on biotherapeutics
Want a window on the future of biopharma? Look no further than cell and gene therapy. This is perhaps one of the most complex fields of biotherapeutics – but one with huge growth potential. Its promise to deliver precision medicines for challenging disease areas ranging from oncology to rare genetic disorders is what makes it so exciting.
Perhaps the most intriguing aspect of precision medicine is the ascent of China to a top table in this sophisticated area. China is establishing itself as a leader not only to spur growth and create jobs, but also as a signal of its position at the cutting edge of a globalized, knowledge-based sector.